Publications by authors named "Darrell R Borger"

50 Publications

Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype.

J Natl Cancer Inst 2017 09;109(9)

Department of Radiation Oncology, Department of Pathology, Division of Biostatistics, Department of Medicine, Division of Medical Oncology, Department of Medicine, Department of Radiology, and Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article and Find Full Text PDF
September 2017

Biliary Adenofibroma of Liver: Morphology, Tumor Genetics, and Outcomes in 6 Cases.

Am J Surg Pathol 2017 Apr;41(4):499-505

*Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada †Massachusetts General Hospital, Boston, MA ‡Oregon Health & Science University, Portland, OR §National Institute of Health/National Cancer Institute, Rockville, MD ∥Caritas Medical Center, Kowloon, Hong Kong ¶University of Florida, Gainesville, FL #University of California San Francisco, San Francisco, CA.

View Article and Find Full Text PDF
April 2017

Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma.

Oncologist 2016 Feb 1;21(2):214-9. Epub 2016 Feb 1.

Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA Division of Hematology/Oncology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

View Article and Find Full Text PDF
February 2016

Microsatellite instability in gallbladder carcinoma.

Virchows Arch 2015 Apr 14;466(4):393-402. Epub 2015 Feb 14.

Pathology Service, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Warren 256, Boston, MA, 02114, USA.

View Article and Find Full Text PDF
April 2015

HER2 over-expressing high grade endometrial cancer expresses high levels of p95HER2 variant.

Gynecol Oncol 2015 Apr 17;137(1):160-6. Epub 2015 Jan 17.

Vincent Center for Reproductive Biology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, United States; Gynecologic Oncology Division, Vincent Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA 02114, United States; Harvard Medical School, Boston, MA 02115, United States.

View Article and Find Full Text PDF
April 2015

Dual HER2 targeting impedes growth of HER2 gene-amplified uterine serous carcinoma xenografts.

Clin Cancer Res 2014 Dec 7;20(24):6517-6528. Epub 2014 Oct 7.

Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, United States.

View Article and Find Full Text PDF
December 2014

Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.

Clin Cancer Res 2014 Jun 8;20(11):2898-909. Epub 2014 Apr 8.

Authors' Affiliations: Department of Neurosurgery; Division of Hematology/Oncology, Department of Neurology, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Translational Research Laboratory; Department of Pathology; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge; Translational Neuro-Oncology Laboratory; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Vesalius Research Center, VIB and Department of Oncology, KU Leuven, Leuven, BelgiumAuthors' Affiliations: Department of Neurosurgery; Division of Hematology/Oncology, Department of Neurology, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Translational Research Laboratory; Department of Pathology; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge; Translational Neuro-Oncology Laboratory; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Vesalius Research Center, VIB and Department of Oncology, KU Leuven, Leuven, BelgiumAuthors' Affiliations: Department of Neurosurgery; Division of Hematology/Oncology, Department of Neurology, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Translational Research Laboratory; Department of Pathology; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge; Translational Neuro-Oncology Laboratory; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Vesalius Research Center, VIB and Department of Oncology, KU Leuven, Leuven, Belgium

View Article and Find Full Text PDF
June 2014

Synergistic effects of targeted PI3K signaling inhibition and chemotherapy in liposarcoma.

PLoS One 2014 2;9(4):e93996. Epub 2014 Apr 2.

Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.

View Article and Find Full Text PDF
November 2014

Inactivation of the tumor suppressor WTX in a subset of pediatric tumors.

Genes Chromosomes Cancer 2014 Jan 5;53(1):67-77. Epub 2013 Nov 5.

Department of Pathology, Massachusetts General Hospital, Boston, MA; Cancer Center, Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA.

View Article and Find Full Text PDF
January 2014